US EditionPublished • loading... • Updated
Pfizer deal’s impact remains unclear as Trump delays drug tariffs
Summary by Scot Scoop News
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Pfizer deal’s impact remains unclear as Trump delays drug tariffs
President Donald Trump recently postponed a planned 100% tariff on imported pharmaceuticals just as Pfizer rolled out a new Medicaid discount program. Under the deal, Pfizer will avoid the tariffs for three years in return for major price cuts for Medicaid patients, with discounts of up to 85% available through a government-run “TrumpRx” website set to launch in 2026. U.S. patients currently pay the highest prices for prescription drugs — often…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
